CO6270260A2 - Metodos para producir 2`-desoxi-5-azacitidina (decitabina) - Google Patents
Metodos para producir 2`-desoxi-5-azacitidina (decitabina)Info
- Publication number
- CO6270260A2 CO6270260A2 CO10037834A CO10037834A CO6270260A2 CO 6270260 A2 CO6270260 A2 CO 6270260A2 CO 10037834 A CO10037834 A CO 10037834A CO 10037834 A CO10037834 A CO 10037834A CO 6270260 A2 CO6270260 A2 CO 6270260A2
- Authority
- CO
- Colombia
- Prior art keywords
- compound
- formula
- decitabine
- azacitidine
- deoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
Método para la produccion de 2'-desoxi-5-azacitidina (Decitabina) al proporcionar un compuesto de formula (I), en donde R es un sustituyente eliminable conocido per se; y R1 es un sustituyente eliminable; proporcionando también una base sililada de formula (II), en donde R2 es un grupo protector, preferiblemente un residuo de trimetilsililo TMS); haciendo reaccionar juntos el compuesto de formula (I) y el compuesto de formula (II) en un disolvente anhidro adecuado y en presencia de un catalizador adecuado; y eliminando los sustituyentes R del compuesto obtenido para obtener el compuesto 2'-desoxi-5-azacitidina (Decitabina), caracterizado porque dicho catalizador se selecciona del grupo que comprende una sal de un acido sulfonico alifatico o una sal de un acido inorganico fuerte. 1.- Método para producir 2'-desoxi-azacitidina (Decitabina) proporcionando un compuesto de formula (I):En la que R es un sustituyente eliminable conocido per se, preferiblemente alquilcarbonilo (C1-C8), o fenilcarbonilo opcionalmente sustituido, o bencilcarbonilo opcionalmente sustituido; R1 es un sustituyente eliminable, preferiblemente halogeno, preferiblemente cloro, bromo, fl·or, preferiblemente cloro, o un imidato, preferiblemente triclorometil imidato, o un derivado de tio-alquilo, preferiblemente -S-metilo; proporcionando también una base sililada de formula (II): en la que R2 es un grupo protector, preferiblemente un residuo de trimetilsililo (TMS); haciendo reaccionar juntos el compuesto de formula (I) y el compuesto de formula (II) en un disolvente anhidro adecuado y en presencia de un catalizador adecuado, obteniéndose asi el compuesto de la formula (III):y eliminando los sustituyentes R para obtener el compuesto 2'-desoxi-azacitidina (Decitabina), caracterizado porque dicho catalizador se selecciona del grupo que comprende una sal de acido sulfonico alifatico o una sal de un acido inorganico fuerte.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07019826A EP2050757A1 (en) | 2007-10-10 | 2007-10-10 | Method of producing 2' -deoxy-5-azacytidine (Decitabine) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6270260A2 true CO6270260A2 (es) | 2011-04-20 |
Family
ID=39496166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO10037834A CO6270260A2 (es) | 2007-10-10 | 2010-04-05 | Metodos para producir 2`-desoxi-5-azacitidina (decitabina) |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20100222565A1 (es) |
| EP (2) | EP2050757A1 (es) |
| JP (1) | JP5453279B2 (es) |
| KR (1) | KR101551779B1 (es) |
| CN (1) | CN102037003B (es) |
| AP (1) | AP2719A (es) |
| AU (1) | AU2008309552B2 (es) |
| BR (1) | BRPI0818595B1 (es) |
| CA (1) | CA2703560C (es) |
| CO (1) | CO6270260A2 (es) |
| CY (1) | CY1116540T1 (es) |
| DK (1) | DK2201020T3 (es) |
| EA (1) | EA018924B1 (es) |
| EC (1) | ECSP10010091A (es) |
| ES (1) | ES2512591T3 (es) |
| GT (1) | GT201000076A (es) |
| HK (1) | HK1152312A1 (es) |
| HN (1) | HN2010000654A (es) |
| HR (1) | HRP20140856T1 (es) |
| IL (1) | IL204918A0 (es) |
| MX (1) | MX2010003887A (es) |
| MY (1) | MY150047A (es) |
| NI (1) | NI201000049A (es) |
| NZ (1) | NZ584373A (es) |
| PL (1) | PL2201020T3 (es) |
| PT (1) | PT2201020E (es) |
| SI (1) | SI2201020T1 (es) |
| SV (1) | SV2010003523A (es) |
| UA (1) | UA101482C2 (es) |
| UY (1) | UY31388A1 (es) |
| WO (1) | WO2009047313A2 (es) |
| ZA (1) | ZA201002517B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2048151A1 (en) * | 2007-10-10 | 2009-04-15 | Cilag AG | Method for producing nucleosides by direct glycosylation of the nucleoside base |
| US8586729B2 (en) * | 2008-10-03 | 2013-11-19 | Scinopharm Taiwan Ltd. | Synthesis of decitabine |
| EP2424845A4 (en) * | 2009-04-27 | 2014-03-05 | Reddys Lab Ltd Dr | PREPARATION OF DECITABIN |
| IT1399195B1 (it) * | 2010-03-30 | 2013-04-11 | Chemi Spa | Processo per la sintesi di azacitidina e decitabina |
| CN101948493A (zh) * | 2010-06-28 | 2011-01-19 | 江苏奥赛康药业有限公司 | 一种高纯度地西他滨的工业化生产方法 |
| KR101241321B1 (ko) * | 2010-08-05 | 2013-03-11 | 케이피엑스 라이프사이언스 주식회사 | 수율 및 순도가 개선된 데시타빈의 제조방법 |
| CN102391338A (zh) * | 2011-09-30 | 2012-03-28 | 重庆泰濠制药有限公司 | 一种地西他滨中间体粗品的纯化方法 |
| CN104211743A (zh) * | 2013-05-29 | 2014-12-17 | 南京工业大学 | 一种地西他宾的合成 |
| CN103601768B (zh) * | 2013-11-13 | 2015-09-30 | 齐鲁天和惠世制药有限公司 | 一种阿米卡星的制备方法 |
| DK3383406T3 (da) * | 2015-12-03 | 2022-01-10 | Epidestiny Inc | Sammensætninger indeholdende decitabin, 5-azacytidin og tetrahydrouridin og anvendelser deraf |
| CN109912672B (zh) * | 2019-04-02 | 2021-07-27 | 江西师范大学 | 一种以邻炔基苯酚醚作为离去基的碱基糖苷化的方法 |
| CN112209977B (zh) * | 2019-07-10 | 2023-05-26 | 鲁南制药集团股份有限公司 | 一种地西他滨中间体化合物ⅵ |
| CN112209976B (zh) * | 2019-07-10 | 2023-05-26 | 鲁南制药集团股份有限公司 | 一种地西他滨中间体化合物ⅴ |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2012888C3 (de) * | 1970-03-14 | 1981-04-02 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden |
| DE2508312A1 (de) * | 1975-02-24 | 1976-09-02 | Schering Ag | Neues verfahren zur herstellung von nucleosiden |
| DE2757365A1 (de) * | 1977-12-20 | 1979-06-21 | Schering Ag | Neues verfahren zur herstellung von nucleosiden |
| US5606048A (en) | 1992-06-22 | 1997-02-25 | Eli Lilly And Company | Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides |
| US5426183A (en) * | 1992-06-22 | 1995-06-20 | Eli Lilly And Company | Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides |
| UA41261C2 (uk) * | 1992-06-22 | 2001-09-17 | Елі Ліллі Енд Компані | Спосіб одержання збагачених бета-аномером нуклеозидів |
| WO1995012593A1 (fr) * | 1993-11-05 | 1995-05-11 | The Noguchi Institute | Derive de 5-0-pyrimidyle-2,3-didesoxy-1-thiofuranoside, procede de production et utilisation |
| WO1997016456A1 (en) * | 1995-11-02 | 1997-05-09 | Chong Kun Dang Corp. | Novel nucleoside derivatives and process for preparing the same |
| DE69921829T2 (de) * | 1998-08-12 | 2005-10-27 | Gilead Sciences, Inc., Foster City | Verfahren zur herstellung von 1,3-oxathiolannukleoside |
-
2007
- 2007-10-10 EP EP07019826A patent/EP2050757A1/en not_active Withdrawn
-
2008
- 2008-10-10 UY UY31388A patent/UY31388A1/es active IP Right Grant
- 2008-10-10 EA EA201070437A patent/EA018924B1/ru unknown
- 2008-10-10 MX MX2010003887A patent/MX2010003887A/es active IP Right Grant
- 2008-10-10 AU AU2008309552A patent/AU2008309552B2/en active Active
- 2008-10-10 US US12/682,293 patent/US20100222565A1/en not_active Abandoned
- 2008-10-10 NZ NZ584373A patent/NZ584373A/en unknown
- 2008-10-10 SI SI200831289T patent/SI2201020T1/sl unknown
- 2008-10-10 BR BRPI0818595-6A patent/BRPI0818595B1/pt active IP Right Grant
- 2008-10-10 ES ES08805203.0T patent/ES2512591T3/es active Active
- 2008-10-10 PT PT88052030T patent/PT2201020E/pt unknown
- 2008-10-10 EP EP08805203.0A patent/EP2201020B1/en active Active
- 2008-10-10 MY MYPI2010001611A patent/MY150047A/en unknown
- 2008-10-10 CN CN200880111108.0A patent/CN102037003B/zh active Active
- 2008-10-10 WO PCT/EP2008/063581 patent/WO2009047313A2/en active Application Filing
- 2008-10-10 DK DK08805203.0T patent/DK2201020T3/da active
- 2008-10-10 UA UAA201004166A patent/UA101482C2/ru unknown
- 2008-10-10 AP AP2010005226A patent/AP2719A/xx active
- 2008-10-10 PL PL08805203T patent/PL2201020T3/pl unknown
- 2008-10-10 JP JP2010528403A patent/JP5453279B2/ja active Active
- 2008-10-10 CA CA2703560A patent/CA2703560C/en active Active
- 2008-10-10 KR KR1020107009760A patent/KR101551779B1/ko active IP Right Grant
-
2010
- 2010-04-05 CO CO10037834A patent/CO6270260A2/es active IP Right Grant
- 2010-04-06 GT GT201000076A patent/GT201000076A/es unknown
- 2010-04-08 IL IL204918A patent/IL204918A0/en active IP Right Grant
- 2010-04-09 EC EC2010010091A patent/ECSP10010091A/es unknown
- 2010-04-09 NI NI201000049A patent/NI201000049A/es unknown
- 2010-04-09 ZA ZA2010/02517A patent/ZA201002517B/en unknown
- 2010-04-09 HN HN2010000654A patent/HN2010000654A/es unknown
- 2010-04-09 SV SV2010003523A patent/SV2010003523A/es unknown
-
2011
- 2011-06-21 HK HK11106364.2A patent/HK1152312A1/xx unknown
-
2014
- 2014-09-10 HR HRP20140856AT patent/HRP20140856T1/hr unknown
- 2014-10-15 CY CY20141100844T patent/CY1116540T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6270260A2 (es) | Metodos para producir 2`-desoxi-5-azacitidina (decitabina) | |
| AR067346A1 (es) | Derivados de bencimidazol | |
| PE20211784A1 (es) | Tolillo sustituido como fungicidas | |
| PE20180799A1 (es) | Reguladores de nrf2 | |
| PE20071322A1 (es) | Derivados de 2-morfolinopirimidina como inhibidores de fosfatidinoinositol(pi) 3-quinasa | |
| PE20091099A1 (es) | Derivados de aminobenzamida como agentes utiles para controlar parasitos animales | |
| PE20130375A1 (es) | Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos | |
| PE20142282A1 (es) | Nuevos derivados de aril-quinolina | |
| UY25204A1 (es) | Agonistas de prostaglandinas útiles en el tratamiento de desórdenes óseos | |
| PE20161405A1 (es) | Analogos de cortistatina y sintesis y usos de los mismos | |
| HRP20080510T3 (en) | Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol | |
| PE20140968A1 (es) | Derivados de benzamida sustituida | |
| PE20091450A1 (es) | INHIBIDORES DE LA ESTEAROIL-CoA-DESATURASA | |
| AR050266A1 (es) | Derivados de bencil-triazolona como inhibidores no nucleosidos de transcriptasa inversa | |
| UY32460A (es) | Derivados de ciclopropilamida '983" | |
| PE20211809A1 (es) | Derivados de espirocromano | |
| AR048875A1 (es) | Un proceso para preparar montelukast y compuestos intermedios para el mismo | |
| AR079294A1 (es) | Acidos homoglutamico y acidos glutamico marcados con yodo y metodo de preparacion de los mismos | |
| AR056783A1 (es) | PROCEDIMIENTO PARA LA FABRICACIoN DE DERIVADOS DE 2-OXO-BENZOXAZINA | |
| RU2014142621A (ru) | Химический способ получения спироиндолонов и их промежуточных соединений | |
| PE20081342A1 (es) | Derivados eter como moduladores duales de los receptores de 5-ht2a y d3 | |
| AR038930A1 (es) | Proceso para sintetizar n-arilpiperazinas con sustitucion con n'-1-(benzoil(2-piridil)amino)-2-propano quiral | |
| CL2018000278A1 (es) | Derivados de etinilo | |
| AR066086A1 (es) | Derivados de dihidro-benzo (b)(1,4)diazepin-2-ona-sulfonamida | |
| ATE465999T1 (de) | Verfahren zur herstellung substituierter pyrimidine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Application granted |